Bortezomib With Gemcitabine/Doxorubicin in Patients With Urothelial Cancer and Other Solid Tumors
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
Instituto do Cancer do Estado de São Paulo
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
AstraZeneca
Astellas Pharma Inc
University of California, San Francisco
University of Oklahoma
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Emory University
University of Nebraska
Jonsson Comprehensive Cancer Center
M.D. Anderson Cancer Center
Nagoya University
University of Chicago
Fox Chase Cancer Center
Astellas Pharma Inc
Eli Lilly and Company
National Cancer Institute (NCI)
Altor BioScience
Dana-Farber Cancer Institute
National Cancer Institute (NCI)
Hoosier Cancer Research Network
Eli Lilly and Company
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group
pharmaand GmbH
Mayo Clinic
Wake Forest University Health Sciences
National Institutes of Health Clinical Center (CC)
University of California, Davis
Imperial College London
Fox Chase Cancer Center
UNICANCER
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Abramson Cancer Center at Penn Medicine
City of Hope Medical Center
National Cancer Institute (NCI)
Karolinska University Hospital